Alan Prem Kumar

26.2k total citations · 8 hit papers
251 papers, 19.3k citations indexed

About

Alan Prem Kumar is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Alan Prem Kumar has authored 251 papers receiving a total of 19.3k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Molecular Biology, 61 papers in Cancer Research and 59 papers in Oncology. Recurrent topics in Alan Prem Kumar's work include Cytokine Signaling Pathways and Interactions (29 papers), Cancer-related molecular mechanisms research (25 papers) and Natural product bioactivities and synthesis (22 papers). Alan Prem Kumar is often cited by papers focused on Cytokine Signaling Pathways and Interactions (29 papers), Cancer-related molecular mechanisms research (25 papers) and Natural product bioactivities and synthesis (22 papers). Alan Prem Kumar collaborates with scholars based in Singapore, Australia and United States. Alan Prem Kumar's co-authors include Gautam Sethi, Muthu K. Shanmugam, Frank Arfuso, Kwang Seok Ahn, Anupam Bishayee, Xiaoyun Dai, Benny K.H. Tan, Kam M. Hui, Kodappully Sivaraman Siveen and Milad Ashrafizadeh and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Alan Prem Kumar

247 papers receiving 19.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Resveratrol in Cancer Therapy

2017 603 citations Gautam Sethi, Jae‐Young Um et al. International Journal of Molecular Sciences profile →
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors

2014 553 citations Kodappully Sivaraman Siveen, Xiaoyun Dai et al. profile →
Dual role of autophagy in hallmarks of cancer

2017 444 citations Tuan Zea Tan, Shuo Deng et al. profile →
Thymoquinone: Potential cure for inflammatory disorders and cancer

2011 422 citations Chern Chiuh Woo, Alan Prem Kumar et al. Biochemical Pharmacology profile →
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment

2015 395 citations Muthu K. Shanmugam, Frank Arfuso et al. profile →
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling

2022 393 citations Kiavash Hushmandi, Gautam Sethi et al. profile →
Antioxidant response elements: Discovery, classes, regulation and potential applications

2018 369 citations Frank Arfuso, Alan Prem Kumar et al. profile →
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds

2023 137 citations Hui Li Ang, Chakrabhavi Dhananjaya Mohan et al. Medicinal Research Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan Prem Kumar Singapore	84	11.2k	4.2k	3.7k	1.8k	1.7k	251	19.3k
Kwang Seok Ahn South Korea	77	10.5k 0.9×	3.1k 0.8×	3.7k 1.0×	1.9k 1.1×	2.0k 1.2×	361	19.0k
Jing‐Gung Chung Taiwan	69	10.4k 0.9×	2.7k 0.6×	2.0k 0.5×	1.3k 0.8×	1.4k 0.8×	550	18.8k
Zigang Dong United States	88	17.1k 1.5×	4.4k 1.1×	5.7k 1.5×	3.1k 1.7×	852 0.5×	578	28.0k
Ann M. Bode United States	77	12.4k 1.1×	3.3k 0.8×	4.1k 1.1×	2.4k 1.3×	670 0.4×	422	21.1k
Muthu K. Shanmugam Singapore	62	6.7k 0.6×	2.0k 0.5×	2.5k 0.7×	1.2k 0.7×	1.1k 0.7×	106	11.7k
Bokyung Sung United States	63	7.6k 0.7×	1.9k 0.4×	2.6k 0.7×	834 0.5×	1.3k 0.7×	157	16.3k
Subash C. Gupta India	55	8.6k 0.8×	2.7k 0.6×	1.7k 0.5×	829 0.5×	1.0k 0.6×	123	19.0k
Mingyao Liu China	70	10.2k 0.9×	2.0k 0.5×	3.2k 0.9×	765 0.4×	781 0.5×	424	17.2k
Jai‐Sing Yang Taiwan	64	7.3k 0.6×	1.8k 0.4×	1.6k 0.4×	1.0k 0.6×	857 0.5×	344	13.3k
Fazlul H. Sarkar United States	100	18.9k 1.7×	9.0k 2.2×	9.9k 2.7×	4.0k 2.2×	986 0.6×	466	33.7k

Countries citing papers authored by Alan Prem Kumar

Since Specialization

Citations

This map shows the geographic impact of Alan Prem Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Prem Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Prem Kumar more than expected).

Fields of papers citing papers by Alan Prem Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Prem Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Prem Kumar. The network helps show where Alan Prem Kumar may publish in the future.

Co-authorship network of co-authors of Alan Prem Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Prem Kumar. A scholar is included among the top collaborators of Alan Prem Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Prem Kumar. Alan Prem Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Bharati Kadamb, Yee Kit Tai, Tuan Zea Tan, et al.. (2025). Fecal Microbiota Transplantation from Mice Receiving Magnetic Mitohormesis Treatment Reverses High-Fat Diet-Induced Metabolic and Osteogenic Dysfunction. International Journal of Molecular Sciences. 26(12). 5450–5450. 1 indexed citations

Lam, Hiu Yan, et al.. (2025). Epigenetic Control of Redox Pathways in Cancer Progression. Antioxidants and Redox Signaling. 42(16-18). 848–867. 3 indexed citations

Goleij, Pouya, Mohammad Amin Khazeei Tabari, Mohadeseh Poudineh, et al.. (2025). Therapeutic potential of melatonin-induced mitophagy in the pathogenesis of Alzheimer’s disease. Inflammopharmacology. 33(8). 4553–4575. 1 indexed citations

Goleij, Pouya, Pantea Majma Sanaye, Mohammad Amin Khazeei Tabari, et al.. (2024). Phytostilbenes in lymphoma: Focuses on the mechanistic and clinical prospects of resveratrol, pterostilbene, piceatannol, and pinosylvin. Leukemia Research. 138. 107464–107464. 12 indexed citations

Goleij, Pouya, Mohammad Amin Khazeei Tabari, Pantea Majma Sanaye, et al.. (2024). Unlocking the Potential: How Flavonoids Affect Angiogenesis, Oxidative Stress, Inflammation, Proliferation, Invasion, and Alter Receptor Interactions in Endometriosis. Food Science & Nutrition. 13(1). e4607–e4607. 7 indexed citations

Goleij, Pouya, Mohammad Amin Khazeei Tabari, Aryan Rezaee, et al.. (2024). Translating molecular insights into clinical success: alkaloid-based therapies for leukemia. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(3). 2547–2568.

Lyu, Juncheng, Rahul Singh, Hiu Yan Lam, et al.. (2024). The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer. Cell Death Discovery. 10(1). 414–414. 7 indexed citations

Ang, Hui Li, Chakrabhavi Dhananjaya Mohan, Muthu K. Shanmugam, et al.. (2023). Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds. Medicinal Research Reviews. 43(4). 1141–1200. 137 indexed citations breakdown →

Mohan, Chakrabhavi Dhananjaya, Muthu K. Shanmugam, Young Yun Jung, et al.. (2023). CXCR4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12/CXCR4 signaling axis in preclinical breast cancer model. Environmental Research. 232. 116335–116335. 14 indexed citations

10.

Kumar, Aviral, et al.. (2022). Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects. Pharmaceuticals. 15(5). 624–624. 20 indexed citations

11.

Yu, Junhong, Iris Rawtaer, Lei Feng, et al.. (2021). Mindfulness intervention for mild cognitive impairment led to attention-related improvements and neuroplastic changes: Results from a 9-month randomized control trial. Journal of Psychiatric Research. 135. 203–211. 34 indexed citations

12.

Ashrafizadeh, Milad, Hui Li Ang, Ebrahim Rahmani Moghadam, et al.. (2020). MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy. Biomolecules. 10(7). 1040–1040. 72 indexed citations

13.

Rangappa, Kanchugarakoppal S., Lan Ma, Tao Zhu, et al.. (2019). Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma. Cancers. 11(10). 1528–1528. 22 indexed citations

14.

Halim, Clarissa Esmeralda, Lu Fan, Frank Arfuso, et al.. (2019). Anti-cancer effects of oxymatrine are mediated through multiple molecular mechanism(s) in tumor models. Pharmacological Research. 147. 104327–104327. 66 indexed citations

15.

Deng, Shuo, Muthu K. Shanmugam, Alan Prem Kumar, et al.. (2019). Targeting autophagy using natural compounds for cancer prevention and therapy. Cancer. 125(8). 1228–1246. 259 indexed citations

16.

Dai, Xiaoyun, Kwang Seok Ahn, Ling Zhi Wang, et al.. (2016). Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 15(12). 2966–2976. 82 indexed citations

17.

Ramachandran, Lalitha, Kanjoormana Aryan Manu, Muthu K. Shanmugam, et al.. (2012). Isorhamnetin Inhibits Proliferation and Invasion and Induces Apoptosis through the Modulation of Peroxisome Proliferator-activated Receptor γ Activation Pathway in Gastric Cancer. Journal of Biological Chemistry. 287(45). 38028–38040. 126 indexed citations

18.

Kumar, Alan Prem. (2011). RNA helicase DDX20, a novel prognostic marker defi nes metastatic potential of breast cancer. Journal of Molecular Biomarkers & Diagnosis. 2(1).

19.

Woo, Chern Chiuh, et al.. (2011). Thymoquinone: Potential cure for inflammatory disorders and cancer. Biochemical Pharmacology. 83(4). 443–451. 422 indexed citations breakdown →

20.

Kumar, Alan Prem, Ting Zhou, Rajeev Singh, et al.. (2009). Repression of NHE1 Expression by PPARγ Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo. Cancer Research. 69(22). 8636–8644. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact